APA (7th ed.) Citation

Murphy, P., Moline, M., Mayleben, D., Rosenberg, R., Zammit, G., Pinner, K., . . . Satlin, A. (2017). Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study. Journal of clinical sleep medicine, 13(11), 1289-1299. https://doi.org/10.5664/jcsm.6800

Chicago Style (17th ed.) Citation

Murphy, Patricia, et al. "Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study." Journal of Clinical Sleep Medicine 13, no. 11 (2017): 1289-1299. https://doi.org/10.5664/jcsm.6800.

MLA (9th ed.) Citation

Murphy, Patricia, et al. "Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study." Journal of Clinical Sleep Medicine, vol. 13, no. 11, 2017, pp. 1289-1299, https://doi.org/10.5664/jcsm.6800.